Instructions for authors and contributors
MakingPharmaIndustry Working Papers welcomes original contributions, analytical papers, industry reports, policy reflections and interdisciplinary studies related to the pharmaceutical industry, life sciences, healthcare innovation, regulatory affairs, manufacturing, market dynamics, sustainability, digital transformation and organizational change.
The series is intended to provide a structured, traceable and citable environment for high-quality editorial and research-based content, with dedicated HTML pages, downloadable full-text PDFs, bibliographic metadata and DOI assignment through Zenodo, when available.
Types of contributions
The series may consider different types of contributions, including:
- analytical papers;
- industry reports;
- policy and regulatory reflections;
- market and scenario analyses;
- research-based editorial contributions;
- interdisciplinary studies;
- position papers;
- extended essays on strategic topics relevant to pharma and life sciences.
Submissions should be original, clearly documented and aligned with the scope of the series.
Language
Papers are preferably submitted in English.
Italian-language contributions may be considered when the topic is specifically related to the Italian pharmaceutical, regulatory, industrial or healthcare context. In such cases, an English title, abstract and keywords may be requested.
Manuscript structure
Submitted papers should include:
- title;
- author name and affiliation;
- author contact information;
- abstract;
- keywords;
- main text;
- references;
- disclosure of potential conflicts of interest;
- indication of any use of generative artificial intelligence tools, where relevant.
The recommended length may vary depending on the type of contribution. As a general indication, Working Papers should normally be between 3,000 and 8,000 words, including references.
Abstract and keywords
Each submission should include an abstract summarizing the purpose, scope and main arguments of the paper.
Authors should also provide 4 to 8 keywords to support discoverability, indexing and thematic classification.
References
References should be accurate, transparent and sufficient to support the arguments, data and claims presented in the paper.
Authors are encouraged to refer to primary sources whenever possible, including scientific literature, regulatory documents, institutional reports, official statistics, policy documents and authoritative industry sources.
Editorial assessment
All submissions are assessed by the MakingPharmaIndustry editorial office for relevance, clarity, originality, documentation, consistency with the scope of the series and compliance with publication ethics.
When appropriate, submissions may be reviewed by external subject-matter experts selected according to the topic of the contribution.
The review process is not intended to replace formal academic peer review unless explicitly stated for a specific paper.
Open access and DOI
Accepted papers are published in open access on MakingPharmaIndustry, with a dedicated HTML page and downloadable full-text PDF.
A DOI may be assigned through Zenodo when the paper meets the editorial and technical requirements for long-term archiving and citation.
Conflicts of interest
Authors are required to disclose any financial, professional, institutional or personal relationships that could be perceived as influencing the content of the paper.
Disclosures may be published together with the paper.
Use of generative artificial intelligence
If generative artificial intelligence tools have been used in the preparation of a manuscript, authors should disclose their use where relevant.
Authors remain fully responsible for the accuracy, originality, integrity and final content of the submitted paper.
Generative AI tools should not be listed as authors.
How to submit
Authors and contributors interested in submitting a paper may contact the editorial office of MakingPharmaIndustry.
Please include:
- proposed title;
- author name and affiliation;
- short abstract or outline;
- expected type of contribution;
- contact information.
Submissions and proposals can be sent to:
